Ingalls & Snyder LLC’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,574
| Closed | -$208K | – | 460 |
|
|
2024
Q4 | $208K | Sell |
1,574
-25
| -2% | -$3.52K | 0.01% | 406 |
|
|
2024
Q3 | $233K | Buy |
+1,599
| New | +$231K | 0.01% | 397 |
|
|
2023
Q4 | – | Sell |
-2,530
| Closed | -$309K | – | 454 |
|
|
2023
Q3 | $309K | Sell |
2,530
-10
| -0.4% | -$1.27K | 0.01% | 338 |
|
|
2023
Q2 | $322K | Sell |
2,540
-29
| -1% | -$3.77K | 0.02% | 343 |
|
|
2023
Q1 | $332K | Hold |
2,569
| – | – | 0.02% | 329 |
|
|
2022
Q4 | $337K | Sell |
2,569
-15
| -0.6% | -$1.94K | 0.02% | 329 |
|
|
2022
Q3 | $302K | Hold |
2,584
| – | – | 0.02% | 337 |
|
|
2022
Q2 | $304K | Sell |
2,584
-100
| -4% | -$11.9K | 0.02% | 344 |
|
|
2022
Q1 | $350K | Sell |
2,684
-225
| -8% | -$29.3K | 0.02% | 344 |
|
|
2021
Q4 | $444K | Sell |
2,909
-286
| -9% | -$44.3K | 0.02% | 329 |
|
|
2021
Q3 | $517K | Sell |
3,195
-55
| -2% | -$9.26K | 0.02% | 304 |
|
|
2021
Q2 | $532K | Buy |
3,250
+285
| +10% | +$43.9K | 0.02% | 306 |
|
|
2021
Q1 | $446K | Sell |
2,965
-566
| -16% | -$89.9K | 0.02% | 309 |
|
|
2020
Q4 | $535K | Sell |
3,531
-2,309
| -40% | -$330K | 0.03% | 277 |
|
|
2020
Q3 | $791K | Buy |
5,840
+340
| +6% | +$46.1K | 0.05% | 202 |
|
|
2020
Q2 | $752K | Buy |
5,500
+283
| +5% | +$36.1K | 0.04% | 221 |
|
|
2020
Q1 | $562K | Sell |
5,217
-379
| -7% | -$43.6K | 0.04% | 251 |
|
|
2019
Q4 | $674K | Sell |
5,596
-253
| -4% | -$28.2K | 0.04% | 239 |
|
|
2019
Q3 | $582K | Sell |
5,849
-3,051
| -34% | -$319K | 0.03% | 271 |
|
|
2019
Q2 | $971K | Sell |
8,900
-40
| -0.4% | -$4.25K | 0.05% | 227 |
|
|
2019
Q1 | $999K | Sell |
8,940
-4,167
| -32% | -$457K | 0.05% | 219 |
|
|
2018
Q4 | $1.26M | Sell |
13,107
-1,245
| -9% | -$132K | 0.07% | 186 |
|
|
2018
Q3 | $1.75M | Sell |
14,352
-145
| -1% | -$17.1K | 0.07% | 181 |
|
|
2018
Q2 | $1.59M | Buy |
14,497
+1,933
| +15% | +$207K | 0.07% | 168 |
|
|
2018
Q1 | $1.34M | Sell |
12,564
-654
| -5% | -$72.5K | 0.07% | 180 |
|
|
2017
Q4 | $1.41M | Buy |
13,218
+1,347
| +11% | +$144K | 0.06% | 181 |
|
|
2017
Q3 | $1.32M | Sell |
11,871
-924
| -7% | -$98.8K | 0.07% | 167 |
|
|
2017
Q2 | $1.32M | Buy |
12,795
+6,414
| +101% | +$632K | 0.07% | 167 |
|
|
2017
Q1 | $624K | Sell |
6,381
-483
| -7% | -$46.2K | 0.03% | 238 |
|
|
2016
Q4 | $607K | Buy |
6,864
+1,701
| +33% | +$155K | 0.03% | 238 |
|
|
2016
Q3 | $498K | Buy |
5,163
+150
| +3% | +$14.3K | 0.03% | 250 |
|
|
2016
Q2 | $430K | Buy |
+5,013
| New | +$450K | 0.03% | 272 |
|
Other funds holding IBB
MMEA
Ingalls & Snyder LLC's IBB Position: Q1 2025 in Review
Ingalls & Snyder LLC sold out of iShares Biotechnology ETF (IBB) in Q1 2025, closing a stake of 1,574 shares — an estimated $208K sold.
Ingalls & Snyder LLC first reported a position in IBB in Q2 2016 and held it in 32 quarters. The position peaked at $1.75M in Q3 2018. 831 funds tracked by Wall St. Rank hold IBB as of Q1 2025.
- Ingalls & Snyder LLC reported no remaining iShares Biotechnology ETF position as of Q1 2025 after selling out during the quarter.
- Ingalls & Snyder LLC sold 1,574 iShares Biotechnology ETF shares in Q1 2025, an estimated $208K.
- Ingalls & Snyder LLC first reported a position in iShares Biotechnology ETF in Q2 2016 and held it in 32 quarters.
- Ingalls & Snyder LLC's iShares Biotechnology ETF position peaked at $1.75M in Q3 2018.
- 831 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2025.
Based on Ingalls & Snyder LLC's 13F filing for Q1 2025, filed 12 May 2025.